Explore

Recent news and media from the Citizen Stash squad.

Experion Reports Record Revenue Growth in Q2 and Reports on Financial and Operational Highlights

VANCOUVER, BC / ACCESSWIRE / July 29, 2020 / Experion Holdings Ltd. (the “Company“ or “Experion”) (TSXV:EXP) (OTCQB:EXPFF) (FRANKFURT:MB31) a cultivator and processor of cannabis products is pleased to announce its financial results for its second quarter, for the period ended May 31, 2020.

Jarrett Malnarich, CEO of Experion, was quoted “Gross Revenue of $1.7 million in Q2 2020, an increase of 114% over last quarter, and YTD a 61% increase over the full year 2019, sets a new record for our Company.  Our strong revenue confirms our ability to cultivate flower at industry-leading levels and the ability to distribute it across Canada. If the events of 2020 to-date have demonstrated anything, they show that the depth and overall competencies of the Experion team are amongst the best in the industry. Our ability to optimize our operations to continue to support our leading brand Citizen Stash without interruption shows just how flexible and efficient we are as a Company. With our ability to scale products and introduce cannabis derivatives, we could not be more excited about the opportunities that lie ahead.”

Key Financial Highlights of the Second Quarter of 2020

  • Revenue increased 114% in the second quarter compared to the first quarter of 2020; YTD revenue of $2.5 million exceeds fiscal 2019 (full year) sales by 61%.
  • Processed and sold 290,058 grams of dried flower YTD through its retail distribution network; an increase of 250% over the same period in the prior year.
  • Achieved an industry high average selling price of $8.59 per gram; an increase of $0.73 compared to the first quarter of 2020.
  • Gross profit improved 21% in the second quarter of 2020 compared to 4% in the previous quarter due to a higher average selling price per gram and increased economies of scale.
  • Successfully reduced operating expenses by $0.9 million (32%) compared to the same period in the prior year.
  • Adjusted EBITDA of $(83,509) represents an increase of $0.7 million compared to the prior quarter.
  • Well positioned balance sheet with current assets of $5.7 million and net working capital of $4.5 million with no debt.

Key Operating Highlights of the Second Quarter of 2020

  • Experion’s consumer brand, Citizen Stash, continues to gain traction in the marketplace which over 600 provincial and private licensed retailers have access to throughout five provinces and two territories across Canada; with the most recent being Ontario.
  • Commercialized 6 new unique cannabis strains to date with another 4 being launched in the next 60 days to complement our existing portfolio.
  • Health Canada approved the license amendment for derivatives in the second quarter of 2020 authorizing Experion to develop, manufacture, sell and distribute cannabis extracts, topicals and edibles to provincial distributors and the adult-use cannabis market across Canada.
  • Experion plans to launch a series of in demand concentrates and edible products under its premium Citizen Stash brand in the next 90 days.
  • Established one of the fastest selling retail brands in Canada, Citizen Stash, offering premium cannabis products.

The management’s discussion and analysis and the accompanying financial statements and notes for the period ended May 31, 2020, are available under the Company’s profile on SEDAR at www.sedar.com.

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent Company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs‘’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP”; on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”.

For further information, please visit the Company’s website www.expertionwellness.com where you can read all news releases or contact Investor Relations, Email: IR@expertionwellness.com.

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Source: Experion Holdings Ltd.

Experion Holdings Announces New Chairman of the Board

VANCOUVER, BC / ACCESSWIRE / July 28, 2020 / Experion Holdings Ltd. (the “Company” or “Experion“) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce the appointment of Mr. Sean MacNeil as Chairman of the Board.

Mr. MacNeil commented “I would like to thank our shareholders and the board for giving me this opportunity to lead Experion.

In 2013 Bob Howard and I proudly founded Experion and since that time the cannabis industry has seen incredible changes. And Experion has been there through it all. There have been many obstacles for everyone in our sector over the past few years, and for each of us that managed to overcome them and survive, the foundation for success is built.

I won’t sugar coat the fact that Experion has had its share of those challenges. Like the gold rushes of the past, the green rush attracted con men and self-anointed experts. But they are leaving, realizing that now is the time to actually perform, the time to provide what consumers have always expected, the time when smoke and mirrors won’t get the job done.

The next phase will see which of the old guard in this new industry will be around in five years and the challenges will be new and many. Experion has a dedicated team of young leaders and the Canadian favorite Citizen Stash brand of products to meet those challenges head on. Experion has a great future.

The cannabis industry is something that I am passionate about, that I understand and have great respect for. Experion will move forward with vigour and I will put my full effort into making it one of Canada’s most respected cannabis companies.”

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Experion Receives Amended Sales License for Derivatives

VANCOUVER, BC / ACCESSWIRE / June 8, 2020 / Experion Holdings Ltd. (the “Company” or “Experion“) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce its wholly-owned subsidiary, Experion Biotechnologies Inc., a licensed cannabis company under the Cannabis Act, has received approval from Health Canada to sell concentrates, topicals and edibles to provincial distributors and medical patients.

Health Canada approved the license amendment authorizing Experion to develop, manufacture, sell and distribute cannabis extracts, topicals and edibles to provincial distributors and the adult-use cannabis market across Canada. This license amendment allows the Company to capitalize on the growing national demand for cannabis derivatives, and accordingly, plans to launch a series of in demand concentrates and edible products under its premium Citizen Stash brand by year end 2020.

“The approval of our amended license under the Cannabis Act is a very exciting milestone for Experion. We can now manufacture and sell all categories of legally designated adult–use cannabis products nationally.” commented Mr. Jarrett Malnarick, CEO of Experion Holdings. “Consumers can look forward to a variety of products and delivery methods offered under our brand Citizen Stash sourced from our premium genetics and strains already available in the market. Key licensing coupled with our expanding distribution network and reputable brand, Citizen Stash, puts Experion in a unique and valuable position as we continue to build a solid path to increased revenue and profitability.”

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Citizen Stash Enters the Province of Ontario

Vancouver, British Columbia, June 2, 2020 / Experion Holdings Ltd. (the “Company“ or “Experion”) (TSXV:EXP) (OTCQB:EXPFF) (FRANKFURT:MB31) is pleased to announce the launch of its premium brand, Citizen Stash, into Ontario where it will be available in stores and online (ocs.ca) in the coming weeks.

The Company’s wholly-owned subsidiary, Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of top shelf cannabis, has signed an agreement with the Ontario Cannabis Store (“OCS”) to officially supply premium cannabis products to the province’s retail network. Ontario is the seventh Canadian province and territory with which Experion has announced distribution and is currently projected to have the largest number of cannabis retailers of any province. Approximately 450 cannabis stores applications were filed in March 2020 under Ontario’s new open-market process.

Mr. Jarrett Malnarich, Chief Executive Officer, commented “We are thrilled to announce our partnership with the OCS and look forward to supplying our high quality in-demand products to cannabis consumers in Ontario long-term. The province is another key milestone for Experion as we continue to build a best-in-class retail distribution network coast to coast for our premium cannabis products to solidify our position in Canada’s cannabis marketplace and take steps towards near-term profitability.”

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Experion Reports AGM Results

VANCOUVER, BC / ACCESSWIRE / May 29 2020 / Experion Holdings Ltd. (the “Company“ or “Experion”) (TSXV:EXP) (OTCQB:EXPFF) (FRANKFURT:MB31) is pleased to announce the results of its annual general and special meeting of the shareholders held on May 27, 2020 (the “Meeting”)

The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved:

  • Fixing the number of directors of the Company at six (6);
  • The election of the following directors: Michael Black, Jarrett Malnarich, Deni Echino, Sean MacNeil, William Dickie and Byron Dudley;
  • Approval of a special resolution to change the registered address of the Company from Alberta to British Columbia;
  • Approval of the Company’s stock option plan; and
  • Appointment of MNP LLP, Chartered Professional Accountants, as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.

Each of the directors elected at the meeting will hold office until the next annual meeting of the Company or until their earlier resignation or removal.  Mr. Jarrett Malnarich accepted the role of Interim Chairman; Mr. Byron Dudley was appointed the Audit Committee Chair and Mr. Sean MacNeil was appointed the Compensation and Governance Chair.

In addition, the Company granted 300,000 Restricted Stock Units (“RSUs”) to its directors and a former director, of which 62,500 RSUs will vest on May 31, 2021, and the remaining 237,500 RSUs will vest 12 months after the directors resign, for their contribution in the first half of fiscal 2020.

CEO Jarrett Malnarich commented. “We are pleased to have our board elected with high acceptance from our voting shareholders.  Having a strong Board is fundamental to Experion as we move forward with our strategy and grow the Company’s valuation in the marketplace.  Our focused mandate to execute our strategic business plan, become profitable, build our team and communicating our strategy gives Experion a sound footing in building a progressive cannabis company.”

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Q2 2020 Strategic Update

VANCOUVER, BC / ACCESSWIRE / May 25 2020 / Experion Holdings Ltd. (the “Company” or “Experion“) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is providing a Strategic Update from the CEO highlighting strategic and operational execution.

Strategic Execution

Experion continues to see tremendous opportunity for Canadian cannabis companies on the path to profitability, despite a difficult market and recent constraints due to the pandemic. We believe steadfast that companies who execute on their core competencies with positive results will weather the current market conditions and be sought out and supported long-term. Experion is such a company. We continue to develop our traditional business fundamentals of operational execution, product quality, effective branding and distribution to drive towards profitability.

In the last quarter, Experion focused its strategic business plan on being a leading processor and distributor of quality cannabis products; and accordingly, is building a clear path to profitability. We have achieved significant revenue growth quarter over quarter since Q4 2019, with the most recent quarter being the strongest in the Company’s history. We anticipate further sales growth of at least 50% in Q2 2020 (see News Release “Experion reports revenue growth First quarter 2020 and fiscal 2019” for more information). Positive financial results demonstrate our ability to focus and execute on our strategic business plan, laying the foundation not only to survive, but to thrive in the coming year.

Effects of COVID-19

To date, the effects of COVID-19 have had a limited impact on the Company’s operations. The supply chain to provincial distributors and retail locations across Canada remains active, but with new logistical challenges.  Since provincial governments declared cannabis products “essential”, access to cannabis has remained available within limits. Despite these restrictions, Experion continues to grow on all fronts including licensed cultivation and processing space, distribution, brand recognition and new product offerings; ultimately, increasing sales. As retail across the country slowly opens, we are optimistic that stakeholders will continue to see the existing momentum created continue in the coming quarters.

Consumer Demand for Quality Craft Cannabis and Citizen Stash

Demand continues to grow for quality cannabis products in Canada. Many retailers and consumers are learning that it is exceptionally difficult to produce old school craft product; let alone deliver quality from large scale commercial operations. Only a handful of companies in the Canadian have been able to provide consistent high-quality cannabis products.  As consumers become more experienced, demand has increased for “premium category” products which is reflected in the purchasing patterns of the provincial exchanges.

Retail is always focused on the next “new” thing and commanding first to market strains and products with a greater emphasis on quality. Original provincial mandates of stockpiling inventory to prevent shortages have migrated to smaller purchases to fill shorter windows of demand with minimum turnover requirements. Experion welcomes these shifts in provincial purchasing as it directly complements our focus on unique genetics, quality, batch sizes and processing ability to meet these needs.

Developing first to market products is key to continuously driving Experion’s retail sales growth and path to profitability. Our premium craft products are supported by our established genetic bank of high-quality commercially viable strains, allowing Experion to launch first to market, craft premium strains for years to come. Our plan for the current year is to introduce an additional three new strains on top of our existing mainstream products. Our ability to process and distribute other licensed producers dried flower further creates a unique opportunity to offer a diverse range of cannabis strains to meet consumer needs.

Experion’s consumer brand, Citizen Stash, has been servicing the premium craft market for more than a year. Citizen Stash continues to be valued in the marketplace for consistently providing a superior consumer experience, causing it to sell out as soon as it hits retail shelves. As the overall market continues to grow, we will further establish our position in the premium category, expanding it across Canada and innovating our premium product offerings to drive revenue and profitability.

Operational Execution

Experion continues to develop, source and package cannabis products for distribution across Canada with a key focus on quality. Our right-sized facility in Mission, BC enables us to cultivate premium genetics and develop, process and package an array of products to meet consumer demand. The unique genetics we cultivate are transitioned to our grow partners once proven for commercialization which we in turn purchase, process and package for distribution across Canada under our consumer brand Citizen Stash. This flower supply will also be utilized to create new cannabis derivate products specific to the strains we cultivate. This business model has allowed us to be operationally nimble to meet the changing provincial and consumer needs by quickly getting products to the market and generating multiple revenue streams.

These are a few of Experion’s operational successes over the past six months:

  • Over 65 Harvests at our Mission, BC Facility: Many competitors were granted licenses at the same time as Experion and are still attempting to build teams that can execute and earn revenue. We have successfully turned over 65 harvests of our product.
  • Co-Cultivation Partnerships: We now have 7 strategic partners growing our genetics which increases our cultivation capacity 5X, with more potential partnerships underway. Cultivation partners are attracted to our model as it allows them to earn revenue without the need for additional licensing or established distribution networks.
  • Increased Licensed Space: Amendment to increase cultivation and processing space approved by Health Canada resulting in:
    • 20% more premium cannabis flower cultivation capacity at our Mission facility;
    • 4X increase in packaging and distribution capabilities; and
    • the ability develop and distribute strain specific value-added products, including pre-rolls and concentrates, allowing us to diversify our product offering.
  • Increased Product Offerings: So far in Q2 2020, two new cannabis strains were introduced under the Citizen Stash brand bringing our portfolio of commercial retail strains to a total of 7. Experion has also successfully launched premium flower pre-rolls to Saskatchewan and BC with Alberta coming online late this month. Similar to Experion’s other high-end cannabis products marketed and sold under Citizen Stash, pre-rolls will extend the premium cannabis experience with a convenient delivery system for our customers. Each pre-roll consists of half a gram of high-quality flower and is 100% strain specific.

Path to Profitability

In Canada, there are almost 400 licensed cannabis companies; however, only approximately 100 can sell products to provincial retailers and conduct medical sales. Experion is a part of this elite group. We continue to build a solid foundation for the future supported by unique genetics, business partners, an established distribution network and management team, and a positive financial position.

Our immediate objective remains the same: increase top quality product volume and distribution to return a profit. To meet this objective, we have identified the following milestones for the remainder of 2020:

  • Fully monetize our processing space to ramp up volume and revenue. The additional processing space at the facility enables Experion to increase the volume of product that can be processed and packaged; creating the potential to improve revenue significantly (4X) without having to deploy additional capital for more capacity. By purchasing product through our supply partners and selling it through our distribution network, we can better meet consumer demand in the near-term. Along with this increased processing capacity, comes the ability to diversify our existing product lines to include pre-rolls, oils and concentrates, creating new experience extensions of our genetics and new revenue streams.
  • Obtain an extraction sales license from Health Canada. This license will enable Experion to sell new value-added, strain specific cannabis products through our established distribution network creating new revenue streams. We anticipate Health Canada to issue the amended license in early Q3 2020, but the timing of such could be impacted by the pandemic.
  • Increase our national distribution footprint. Achieve additional distribution in Ontario and Quebec to support our sales objectives. In addition to registering with these provinces, we plan to target hundreds of additional retailers within our reach through retail and agency relationships to create a pull demand for our product and increase market share.
  • Launch cannabis edibles and derivatives. We are actively partnering with other licensed facilities and industry experts in all areas of cannabis derivatives. Our immediate focus is to launch gummies and concentrates product lines to complement our flower products and extend the experience of our premium flower strains while diversifying revenue.
  • Right-sizing operations. Experion has made significant steps in recent quarters to reduce go forward operating expense by over 30% with the aim of near-term profitability. The effects of these cost reductions will continue to be realized throughout the remaining months of 2020.
  • Expand our investor communications. Experion is committed to keeping both the consumer and investment communities abreast of new developments and milestones. We relaunched Experion’s website to align with our newly focused business strategy and will be publishing tomorrow a new Q2 2020 Investor Presentation. We have transitioned social media in-house for better control over messaging and plan to implement other cost-effective communication tools to inform our communities of any new developments and to reach a wider investor audience.

As we look forward to the next quarter and the remainder of 2020, we are confident that we will continue to position our company as a national leader of top branded cannabis products; standing out from the competition and becoming the logical choice for cannabis investors seeking a profitable growth opportunity.

For more information about our company, plans and frequently asked questions, please visit our website at www.experionwellness.com. For any questions, please contact us at ir@experionwellness.com.

On behalf of the Management team, we thank you for your continued support and look forward to our journey together.

Sincerely,

Jarrett Malnarick, CEO

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Experion reports revenue growth First quarter 2020 and fiscal 2019

Experion Holdings Ltd. (the “Company“ or “Experion”) (TSXV:EXP) (OTCQB:EXPFF) (FRANKFURT:MB31) a cultivator and processor of cannabis products is pleased to announce its financial results for its first quarter, for the period ended February 29, 2020, and its full year as at November 30, 2019.

KEY FINANCIAL HIGHLIGHTS OF THE FIRST QUARTER OF 2020

  • Revenue for the first quarter of 2020 increased to $803,655, an increase of 127% from the fourth quarter of 2019.
  • Since the beginning of the fiscal year, Experion has processed 180,142 grams of dried flower to be sold through the retail distribution channel.
  • Average net selling price per gram was $7.86 an increase of $1.20 compared to the fourth quarter of 2019.
  • Gross profit margin increased to $3% of gross revenue, compared to negative 18% in the prior quarter.
  • Decrease of $682,893 or 41% in expense in the first quarter of 2020 compared to the fourth quarter of 2019.
  • Adjusted EBITDA(1)increased by $1.1 million compared to the prior quarter.
  • Well positioned balance sheet with $3.4 million in cash and net working capital of $4.6 million as at February 29, 2020, with no debt

KEY OPERATING HIGHLIGHTS OF THE FIRST QUARTER OF 2020 AND FOURTH QUARTER OF 2019

  • Reduced operational expenses by at least 30% through optimizing processes, functions and right-sizing the organization.
  • Health Canada approved amendment to license for expanded cultivation and processing space within facility, effectively increasing cultivation by 20% and processing by 100%.
  • Increased distribution and active in 5 provinces and two territories servicing over 600 retailers.
  • Established one of the fastest selling retail brands in Canada, Citizen Stash, offering premium cannabis products.
  • Increased product offerings by launching five new first to market strains and manufacturing and distributing high-quality premium pre-rolls across Canada.

“We are proud to have achieved significant growth quarter over quarter, with the first quarter of 2020 being our strongest to date and anticipate significant revenue growth again in the second quarter of 2020. The financial statements for Q1 2020 reflect the improvements made in all key areas of the company from licensing, facility, product procurement and sales. Our focus on being a leading distributor of cannabis products as well as building a recognized and sought-after brand will continue to drive the Company to profit,” commented Experion Holdings CEO, Jarrett Malnarick. “These results demonstrate the vision and abilities of our management team and expect to continue this high level of performance and positive results going forward.”

Furthermore, Mr. Malnarick stated, “Management recently decided to not close on the debt facility previously announced in early February 2020 with Trichome Financial. We believe that we can achieve our initial business objectives of becoming a leading distributor of premium cannabis products in Canada with our strong balance sheet and continued sales momentum. Trichome continues to be a valuable business partner to Experion as the relationship moves towards short-term financing opportunities to support working capital as the Company ramps up its distribution model. We are excited about the opportunities to come and the future of the cannabis industry.”

The management’s discussion and analysis and the accompanying financial statements and notes for the period ended February 29, 2020, and for the year-ended November 30, 2019, are available under the Company’s profile on SEDAR at www.sedar.com.

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Experion Launches New Citizen Stash Branded Pre-Roll Line of Products

VANCOUVER, BC / ACCESSWIRE / MAY 06, 2020 / Experion Holdings Ltd. (the “Company” or “Experion“) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce that it is now manufacturing and distributing premium cannabis pre-rolls; and has shipped its first order to Saskatchewan.

Similar to Experion’s other high-end cannabis products marketed and sold under its consumer brand, Citizen Stash, pre-rolls will extend the premium cannabis experience with a convenient delivery system for our customers. Each pre-roll consists of half a gram of high-quality flower and is 100% strain specific.

The first order of over 8,500 pre-rolls will be delivered to Saskatchewan this week with shipments to BC and Alberta expected to follow later this month. According to a Statistics Canada report ending 2019, over 20% of the flower market continues to be sold in pre-rolls.

Mr. Jarrett Malnarick, CEO of Experion commented “We are excited to launch our new line of pre-rolled cannabis products this week. Citizen Stash pre-rolls are 100% flower strain specific designed to reflect the market’s appreciation for quality and value while providing a unique experience. Pre-rolls have generally been viewed as a means for producers to sell their low-quality flower and by-products. Like all our Citizen Stash branded products, we believe our new premium strain specific pre-rolls will appeal to discerning consumers looking for top shelf quality at a competitive price. Additionally, this new product offering represents another potential high growth revenue stream for the Company as we push toward profitability in 2020”.

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Experion AGM, Annual and Quarterly Filing Update

VANCOUVER, BC / ACCESSWIRE / April 29 2020 / Experion Holdings Ltd. (the “Company” or “Experion“) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is providing an update on the Company’s AGM and the status of the filing of its annual financial statements for the year ended November 30, 2019, and its first quarter 2020 financial statements for the period ended February 29, 2020.

Virtual AGM Access

To proactively deal with the unprecedented health impact of coronavirus disease, also known as COVID-19; to mitigate risks to the health and safety of our communities, shareholders, employees and other stakeholders; to comply with current government directives and advice to which we will continue to adhere, we will hold our Annual General Meeting on Wednesday, May 27, 2020 at 11:00AM Pacific Time in a virtual only format, via live audiocast.

Registered Shareholders and duly appointed proxyholders can attend the Meeting online where they can participate, vote, and submit limited questions during the Meeting’s live webcast. Shareholders can find instructions on how to register on their voting instruction form found in the management information circular relating to the annual general meeting.

2019 Annual Report and Q1 2020 Filing Update

On March 18, 2020, the Canadian Securities Administrators (CSA) announced that they will provide issuers with a 45-day filing extension for filings required on or before June 1, 2020 to allow issuers the time needed to focus on the many other business and financial reporting implications of COVID-19. Experion will rely on this exemption with respect to the Annual Filings in accordance with BC Instrument 51-515, Temporary Exemption from Certain Corporate Finance Requirements.

The Company is continuing to work diligently and expeditiously with its auditors to file its financial statements, the accompanying management’s discussion and analysis and the related CEO and CFO certifications, for both the full year 2019 and first quarter 2020 results on or around May 11, 2020 and by no later than May 14, 2020.

In the interim, management and other insiders of the Company are subject to a trading black-out policy that reflects the principles in section 9 of National Policy 11-207, Failure to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

The Company confirms that since the filing of its interim consolidated financial statements for the three months ended August 31, 2019, there have been no material business developments other than those disclosed through news releases.

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Experion Holdings Announces AGM to be Hosted Virtually

VANCOUVER, BC / ACCESSWIRE / April 2, 2020 / Experion Holdings Ltd. (the “Company” or “Experion“) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce that its Annual General Meeting of Shareholders (AGM) will be held on Wednesday, May 27, 2020 at 11:00 AM, Pacific Standard Time. The Company is preparing to host a virtual AGM in conjunction with Computershare using a third-party service provider in order to comply with the current national and provincial health restrictions relating to non-essential travel, physical distancing and avoiding gatherings of more than 10 people.

Further details on the virtual AGM will be provided to shareholders as they become available.

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

Stand for Something

Subscribe to our newsletter for updates
and curated content delivered to: